$2.7 billion → $299
The cost to sequence one human genome has fallen from $2.7 billion in 2003 (Human Genome Project) to under $299 in 2026, a decline that outpaces Moore's Law by orders of magnitude. — NHGRI Genome Sequencing Program Data, 2026
What Is Whole Genome Sequencing?
Whole genome sequencing (WGS) is a laboratory method that reads the complete DNA sequence of your entire genome — all 3 billion base pairs — in a single analysis. Your genome is the instruction manual for building and operating your body, written in a four-letter chemical alphabet: A (adenine), T (thymine), C (cytosine), and G (guanine). WGS decodes this entire text, letter by letter.
The human genome contains approximately 20,000 protein-coding genes spread across 23 chromosome pairs. But these genes account for only about 1-2% of your total DNA. The remaining 98-99% — once dismissed as "junk DNA" — contains regulatory regions that control when and where genes are expressed, along with structural elements and repetitive sequences that influence everything from disease risk to drug metabolism.
How Whole Genome Sequencing Works
Modern WGS relies on a technology called sequencing by synthesis (SBS), developed primarily by Illumina. The process works in four stages:
- DNA Extraction: A saliva or blood sample is collected and DNA is isolated from cells.
- Library Preparation: The DNA is randomly fragmented into millions of small pieces (~300–500 base pairs each). Adapters — short synthetic DNA sequences — are attached to both ends of each fragment.
- Sequencing: The fragments are placed on a flow cell where each one is amplified into a cluster of identical copies. Fluorescently labeled nucleotides (A, T, C, G) are washed across the flow cell. Each time a base is added to a growing strand, a camera captures the color of the fluorescence. This happens simultaneously across billions of clusters.
- Data Analysis: The millions of short reads (typically 150 base pairs each) are aligned to a reference genome using computational tools. Variants — places where your DNA differs from the reference — are called, annotated, and filtered. A standard 30x coverage means each position is independently read an average of 30 times, providing built-in error correction.
The entire sequencing run takes 24–48 hours on a modern instrument like the Illumina NovaSeq X, which can sequence up to 20,000 human genomes per year. Data processing and interpretation add 8–12 weeks to the consumer timeline.
WGS vs. Genotyping: The Critical Difference
This is the most important distinction to understand when choosing a DNA test. Consumer tests like 23andMe and AncestryDNA use genotyping — they check 600,000–700,000 specific, pre-selected positions (SNPs) in your genome. That's roughly 0.02% of your DNA. It's like checking the answers on a multiple-choice test where someone else chose the questions.
Whole genome sequencing reads every position — all 3 billion base pairs. This means WGS can detect:
- Rare variants: Mutations too uncommon to be included on genotyping chips, but which may have significant personal health implications
- Structural variants (SVs): Large deletions, duplications, inversions, and translocations that genotyping arrays cannot reliably detect
- Copy number variations (CNVs): Changes in the number of copies of DNA segments, implicated in conditions from autism to cancer susceptibility
- Non-coding variants: Changes in regulatory regions that affect gene expression without altering protein sequence
A practical example: the BRCA1 gene has over 1,800 known disease-associated variants. 23andMe's health report tests for only 3 of them — specifically the three most common in the Ashkenazi Jewish population. A WGS test captures all of them, plus thousands of variants in other cancer-predisposition genes.
What WGS Can Tell You
A comprehensive WGS report from a provider like Nebula Genomics or Dante Labs typically covers:
- Disease Risk: Polygenic risk scores and monogenic disease variants for conditions including cancers, cardiovascular disease, neurodegenerative disorders, and metabolic conditions
- Carrier Status: Whether you carry recessive variants for conditions like cystic fibrosis, Tay-Sachs, or sickle cell disease — critical information for family planning
- Pharmacogenetics: How your genetic profile affects your response to over 300 FDA-labeled medications, including antidepressants, painkillers, blood thinners, and chemotherapy agents
- Ancestry and Traits: Deep ancestry analysis including Neanderthal ancestry percentage, Y-chromosome and mitochondrial DNA haplogroups, and physical traits from earwax type to caffeine metabolism
- Nutritional Genetics: Insights into lactose intolerance, gluten sensitivity risk, vitamin metabolism, and other nutrigenomic traits
What WGS Cannot Tell You
It is equally important to understand the limitations. WGS provides probabilities and predispositions, not certainties. Most common diseases — diabetes, heart disease, most cancers — result from complex interactions between dozens or hundreds of genes and environmental factors. Having a risk variant does not mean you will develop the condition. Not having one does not mean you are immune.
Additionally, many variants found in WGS data are classified as variants of uncertain significance (VUS). This means the scientific community does not yet have enough evidence to determine whether the variant increases disease risk. As research advances, VUS classifications change — a variant labeled uncertain today may be reclassified as pathogenic or benign tomorrow. This is why providers like Nebula Genomics offer subscription-based updates that re-analyze your data against the latest research.
The History of Whole Genome Sequencing
The journey from the Human Genome Project (HGP) to $299 consumer WGS is remarkable:
- 1990–2003: The Human Genome Project sequences the first human genome at a cost of $2.7 billion, involving thousands of scientists across 20 institutions in 6 countries.
- 2007: James Watson's genome is sequenced for approximately $2 million using 454 Life Sciences technology.
- 2014: Illumina's HiSeq X Ten system achieves the $1,000 genome milestone.
- 2018: Veritas Genetics (now part of LetsGetChecked) offers the first consumer WGS for $999.
- 2022: Nebula Genomics introduces 30x WGS for $299, bringing the technology into reach of consumers globally.
- 2026: Prices have stabilized around $299–$999 for consumer WGS, with the NIH continuing to pursue the $100 genome as a research goal.
Who Should Consider Whole Genome Sequencing?
WGS is not for everyone, and it shouldn't be treated as a universal health screening tool — at least not yet. It is most appropriate for:
- People with undiagnosed symptoms or conditions where standard testing has been inconclusive
- Individuals with a strong family history of genetic conditions who want comprehensive assessment
- Those interested in pharmacogenetic testing across hundreds of medications
- People who want a lifetime genetic resource that can be re-analyzed as science advances
- Researchers and citizen scientists comfortable navigating complex genetic findings
If you are primarily interested in basic ancestry composition or a handful of health traits, a genotyping test like 23andMe ($79–$199) likely provides better value. If you have specific medical concerns, consult a genetic counselor before purchasing any test.
Ready to explore whole genome sequencing providers?
Compare WGS ProvidersFrequently Asked Questions
What is the difference between sequencing coverage and depth?
Coverage refers to what percentage of the genome was sequenced at least once. Depth (or read depth) indicates how many times each base pair was independently read, averaged across the genome. 30x depth means each position was read an average of 30 times. Higher depth provides greater confidence in variant calls, particularly for low-frequency variants in heterogeneous samples. Clinical WGS typically requires 30x minimum; research studies sometimes use lower depth (5–10x) for population-scale projects to reduce costs.
Can whole genome sequencing detect all genetic diseases?
No. WGS detects changes in the DNA sequence (single nucleotide variants, insertions/deletions, structural variants, and copy number changes). It does not detect epigenetic modifications (like DNA methylation), mitochondrial DNA at the same depth as nuclear DNA (unless specifically targeted), or protein-level changes. Many diseases — particularly autoimmune conditions, mental health disorders, and metabolic diseases — involve complex gene-environment interactions that cannot be reduced to a single genetic variant. Additionally, some pathogenic variants fall in regions that are technically difficult to sequence due to repetitive sequences or extreme GC content.
How is my genetic data protected?
Data protection varies by provider. Reputable WGS companies encrypt your data at rest and in transit, allow you to delete your data and sample at any time, and publish clear data-sharing policies. The Genetic Information Nondiscrimination Act (GINA) protects against discrimination by health insurers and employers in the United States, but it does not cover life insurance, disability insurance, or long-term care insurance. Always read a provider's privacy policy carefully before submitting a sample. For more detail, see our DNA Privacy Guide.